Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively Samuel R. ChamberlainDavid S. Baldwin Therapy in Practice 09 July 2021 Pages: 703 - 716
The Effect of Statin Treatment on Outcomes of Cardioembolic Stroke: A Systematic Review and Meta-Analysis of Real-World Studies Tao XuYou WangYangmei Chen Systematic Review 21 May 2021 Pages: 717 - 726
Relevance of 5-HT2A Receptor Modulation of Pyramidal Cell Excitability for Dementia-Related Psychosis: Implications for Pharmacotherapy Ethan S. Burstein Review Article Open access 05 July 2021 Pages: 727 - 741
Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex) Stanley L. CohanBarry A. HendinBianca Weinstock-Guttman Review Article Open access 06 July 2021 Pages: 743 - 767
Treatment with Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) and the Risk of All-Cause Poisoning in Children and Adolescents: A Self-Controlled Case Series Study Le GaoKenneth K. C. ManIan C. K. Wong Original Research Article Open access 20 July 2021 Pages: 769 - 779
Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies Richard L. DotyVanina PopovaWayne C. Drevets Original Research Article Open access 07 July 2021 Pages: 781 - 794
Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison Stanley CohanJinender KumarTom Tencer Original Research Article Open access 13 April 2021 Pages: 795 - 804